This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción 5MP0
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de Biodexa Pharmaceuticals Plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.04 |
| 52 Week High | UK£2.50 |
| 52 Week Low | UK£0.01 |
| Beta | 1.13 |
| 1 Month Change | -76.71% |
| 3 Month Change | 304.00% |
| 1 Year Change | -98.38% |
| 3 Year Change | -99.40% |
| 5 Year Change | -99.97% |
| Change since IPO | -99.99% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 5MP0 | DE Biotechs | Mercado DE | |
|---|---|---|---|
| 7D | -17.2% | 0.6% | -1.0% |
| 1Y | -98.4% | -20.9% | 3.9% |
Rentabilidad vs. Industria: 5MP0 underperformed the German Biotechs industry which returned -7% over the past year.
Rentabilidad vs. Mercado: 5MP0 underperformed the German Market which returned 5.9% over the past year.
Volatilidad de los precios
| 5MP0 volatility | |
|---|---|
| 5MP0 Average Weekly Movement | 542.1% |
| Biotechs Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.6% |
Precio estable de las acciones: 5MP0's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 5MP0's weekly volatility has increased from 321% to 542% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 20 | Stephen Stamp | www.biodexapharma.com |
Resumen de fundamentos de Biodexa Pharmaceuticals Plc
| Estadísticas fundamentales de 5MP0 | |
|---|---|
| Capitalización bursátil | €4.01m |
| Beneficios(TTM) | -€6.06m |
| Ingresos (TTM) | €728.56k |
5.5x
Ratio precio-ventas (PS)-0.7x
Ratio precio-beneficio (PE)¿Está 5MP0 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 5MP0 | |
|---|---|
| Ingresos | UK£645.00k |
| Coste de los ingresos | UK£4.65m |
| Beneficio bruto | -UK£4.01m |
| Otros gastos | UK£1.36m |
| Beneficios | -UK£5.37m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.057 |
| Margen bruto | -621.55% |
| Margen de beneficio neto | -832.09% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado 5MP0 a largo plazo?
Ver rendimiento histórico y comparativa